Recent Quotes

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		-0.220		-0.220		0.0000
REV				1.000M

Q4 2020		Est.		Actual		Surprise
EPS		-0.240		-0.200		0.0400
REV		120.000K		0		-120.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
APTX	Aptinyx	3.18	0.08	2.58%		216.8M

Aptinyx Frequently Asked Questions

How do I buy Aptinyx (APTX) stock?

You can purchase shares of Aptinyx (NASDAQ: APTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Aptinyx's (APTX) competitors?

Other companies in Aptinyx’s space includes: Cabaletta Bio (NASDAQ:CABA), Heat Biologics (NASDAQ:HTBX), Galectin Therapeutics (NASDAQ:GALT), T2 Biosystems (NASDAQ:TTOO) and Applied Genetic (NASDAQ:AGTC).

What is the target price for Aptinyx (APTX) stock?

The latest price target for Aptinyx (NASDAQ: APTX) was reported by JP Morgan on January 29, 2021. The analyst firm set a price target for 0.00 expecting APTX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Aptinyx (APTX)?

The stock price for Aptinyx (NASDAQ: APTX) is $3.18 last updated Today at 1:58:12 PM.

Does Aptinyx (APTX) pay a dividend?

There are no upcoming dividends for Aptinyx.

When is Aptinyx (NASDAQ:APTX) reporting earnings?

Aptinyx’s Q2 earnings are confirmed for after-market on August 12, 2021.

Is Aptinyx (APTX) going to split?

There is no upcoming split for Aptinyx.

What sector and industry does Aptinyx (APTX) operate in?

Aptinyx is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.